Every round on record, with the sources behind each and the investors on them.
Develops science-based sleep solutions
romansive.comSouth KoreaHealthtechFounded 2021
3 sources · checked 18 times, last 4h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Tech in Asia reports approximately US$3 million, while Fundup reports ₩4B; the latter is used as the more specific funding-profile figure.; not on the page it cites, so not applied: headquarters
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $3.0M ₩4B | 2026-10-02 | not stated | No recent discussion |
3 sources · checked 18 times, last 4h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 3 sources
Tech in Asia reports approximately US$3 million, while Fundup reports ₩4B; the latter is used as the more specific funding-profile figure.; not on the page it cites, so not applied: headquarters | ||||
Romansive is addressing a gap in Korea's market for a convenient, non-drug sleep aid: its founder started after experiencing insomnia and seeing people use alcohol because they distrusted sleep medication, while the company uses fermented natural ingredients and preclinical and clinical research with Bundang Seoul National University Hospital. The bet is that a science-backed, personalized sleep-food category can scale beyond Korea; Coza has expanded into pharmacies and hotel amenities, and the company has raised 51억원 through Seed, Pre-A and Series A funding.
Checked against 10 sources today
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Pre-A 시리즈 | 8억 원 | 2024-06-24 | not stated | |